Cataract Surgery Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, Japan, China - Size and Forecast 2024-2028

#Snapshot img { margin: 10px !important; } Cataract Surgery Devices Market Size 2024-2028 The cataract surgery devices market size is forecast to increase by USD1.86 billion at a CAGR of 5.21% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The aging population in the US is a major driver, as cataracts are a common condition among older adults. Additionally, the prevalence of chronic diseases, such as diabetes, which increases the risk of cataracts, is also contributing to market growth, particularly in the eyeglasses, as more individuals seek corrective eyewear to manage their vision health. Reimbursement policies and healthcare spending are also significant factors. While cataract surgeries are essential for restoring vision, the high cost and insufficient insurance coverage can be a barrier for many patients. Innovative surgical techniques, such as phacoemulsification and the use of advanced intraocular lenses, are addressing these challenges and improving patient outcomes. Request Free SampleThe market is experiencing significant disruption due to the increasing prevalence of cataract and the aging population. According to the National Eye Institute, approximately 24.4 million Americans aged 40 and above have cataracts or have undergone cataract surgery. This number is projected to increase as the geriatric population continues to grow. Visual impairment caused by cataract blindness results in disability-adjusted life years (DALYs) and significantly impacts the quality of life of affected individuals. The aging population, with its increased susceptibility to chronic diseases, is a significant contributor to the rising prevalence of cataract.Moreover, healthcare spending on ophthalmology procedures, including cataract surgery, is expected to increase due to the growing need for treatment procedures. Phacoemulsification equipment, phacoemulsification machines, and intraocular lenses are some of the essential devices used in cataract surgery. Surgical advantages of cataract surgery, such as minimally invasive surgery, robotic assistance, and telemedicine, are driving the growth of the market. Minimally invasive surgery, for instance, reduces the risk of complications and speeds up recovery time. Robotic assistance offers precision and consistency, ensuring optimal outcomes. Telemedicine enables remote consultations and follow-ups, making cataract surgery more accessible. Innovative surgical techniques, such as those using advanced technology like AI-assisted surgery, are revolutionizing cataract surgery.Furthermore, these techniques offer improved accuracy, reduced human error, and enhanced patient satisfaction. Intraocular lenses, another essential component of cataract surgery, are evolving to cater to the unique needs of patients, such as those with nuclear sclerotic cataracts. The healthcare infrastructure's readiness to accommodate the increasing demand for cataract surgery is a critical factor influencing market growth. As the market matures, competition among manufacturers is expected to intensify, leading to innovations and advancements in cataract surgery devices. Market SegmentationThe market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.ProductIntraocular lens (IOLs)Phacoemulsification devicesOphthalmic viscosurgical devices (OVDs)Femtosecond lasersEnd-userHospitals and clinicsOphthalmology centersGeographyNorth AmericaUSEuropeGermanyUKAsiaChinaJapanRest of World (ROW)By Product InsightsThe intraocular lens (IOLs) segment is estimated to witness significant growth during the forecast period. Intraocular lenses (IOLs) are essential medical devices implanted during cataract surgery to replace the natural lens. These lenses are utilized for treating cataracts and myopia, with refractive lens exchange IOLs specifically designed to correct vision. The market for IOLs is experiencing significant growth due to manufacturers' increasing emphasis on producing advanced, efficient, and safe products. While standard monofocal IOLs address single vision issues, premium IOLs correct multiple types of vision loss, thereby eliminating the need for glasses. The availability of high-definition (HD) IOLs with minimal side effects enables patients to quickly regain clear vision following cataract surgery.Moreover, technological advancements in cataract surgery devices are revolutionizing the industry. Robotic assistance and minimally invasive surgery techniques are gaining popularity due to their precision and reduced risk of complications. Telemedicine is also transforming the sector by enabling remote consultations and post-operative care, thereby enhancing

### 图片快照 { margin: 10px !important; } 青光眼手术设备市场规模 2024-2028 青光眼手术设备市场规模预计将在2023年至2028年期间增长1.86亿美元，年复合增长率达到5.21%。市场增长得益于多个关键因素的推动。美国人口老龄化是主要驱动力，因为白内障是老年人常见的疾病。此外，慢性疾病（如糖尿病）的普遍存在，增加了白内障的风险，也对市场增长产生了贡献，尤其是在眼镜市场，因为越来越多的个人寻求矫正眼镜来管理他们的视力健康。报销政策和医疗保健支出也是重要因素。虽然白内障手术对于恢复视力至关重要，但高昂的费用和保险覆盖不足可能成为许多患者的障碍。创新的手术技术，如超声乳化术和高级人工晶状体的应用，正在解决这些挑战并改善患者预后。 市场正因白内障的日益普遍和人口老龄化而经历重大颠覆。根据美国国立眼科研究所的数据，大约有2440万40岁以上的美国人患有白内障或已接受白内障手术。随着老年人口的持续增长，这一数字预计将增加。由白内障盲引起的视力障碍导致残疾调整生命年（DALYs）并严重影响受影响个体的生活质量。老年人口对慢性疾病的易感性增加是白内障患病率上升的重要因素。此外，由于治疗需求不断增加，眼科手术（包括白内障手术）的医疗保健支出预计将增加。超声乳化设备、超声乳化机和人工晶状体是白内障手术中使用的必要设备。白内障手术的手术优势，如微创手术、机器人辅助和远程医疗，正在推动市场增长。例如，微创手术可降低并发症风险并加快康复时间。机器人辅助提供精确性和一致性，确保最佳结果。远程医疗使远程咨询和随访成为可能，使白内障手术更加便捷。利用先进技术（如AI辅助手术）的创新手术技术正在革新白内障手术。此外，这些技术提供了更高的准确性、减少人为错误和增强患者满意度的优势。人工晶状体作为白内障手术的另一重要组成部分，正在不断发展以满足患者的独特需求，例如那些患有核硬化白内障的患者。医疗保健基础设施准备好满足不断增长的白内障手术需求是影响市场增长的关键因素。随着市场的成熟，制造商之间的竞争预计将加剧，从而推动白内障手术设备的创新和进步。 市场细分 市场研究报告提供了全面的数据（按区域细分的市场分析），包括对2024-2028年期间的预测和估计（以亿美元为单位），以及2018-2022年的历史数据，以下为以下细分市场： 产品 人工晶状体（IOLs） 超声乳化设备 眼科粘弹手术设备（OVDs） 激光设备 最终用户 医院、诊所 眼科中心 地理 北美 美国 欧洲 德国 英国 亚洲 中国 日本 其他地区（ROW） 产品洞察 人工晶状体（IOLs）细分市场预计在预测期间将实现显著增长。人工晶状体（IOLs）是在白内障手术中植入以替代自然晶状体的必要医疗设备。这些镜头用于治疗白内障和近视，特别是设计的折射性晶状体交换人工晶状体，用于纠正视力。由于制造商越来越重视生产高级、高效和安全的产品，IOLs市场正经历显著增长。虽然标准单焦点人工晶状体解决单视问题，但高级人工晶状体可纠正多种类型的视力损失，从而消除了佩戴眼镜的需要。高清晰度（HD）人工晶状体的可用性及其最小副作用使患者能够在白内障手术后的短时间内迅速恢复清晰的视力。此外，白内障手术设备的科技进步正在改变行业。机器人辅助和微创手术技术因精度高、并发症风险低而受到欢迎。远程医疗也通过使远程咨询和术后护理成为可能，从而改变了该领域。